To determine in an unbiased manner if YB-1 or MTA1 mRNA levels are different between normal prostate tissue and prostate cancer, we analyzed 15 human prostate cancer mRNA datasets published between 2001 and 2012 (Table 2), which included 1016 unique patient samples. The gene discussed is MTA1; the disease is prostate carcinoma.